INSULIN ICODEC
UNII P7YU3ED05N

Substance Identification & Data

This profile provides standardized clinical and technical data for Insulin Icodec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P7YU3ED05N.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1188379-43-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P7YU3ED05N

CAS Registry Number

1188379-43-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INSULIN ICODEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175800

National Cancer Institute reference terminology for clinical and research data.

INN ID

11393

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-84

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Insulin Icodec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INSULIN ICODEC

Common Names & Synonyms

INSULIN 287

INSULIN ICODEC [INN]

INSULIN ICODEC [USAN]

INSULIN ICODEC [WHO-DD]

LONG-ACTING-INSULIN-287

NN1535 ICOSEMA COMPONENT INSULIN ICODEC

NN1535 LAISEMA COMPONENT INSULIN ICODEC

Systematic Nomenclature

(1A-21A),(1B-29B)-INSULIN (HUMAN), 14A-L-GLUTAMIC ACID-16B-L-HISTIDINE-25B-L-HISTIDINE-29B-(N6-(N-(19-CARBOXY-1-OXONONADECYL)-L-.GAMMA.-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL)-L-LYSINE)-

SYS

HUMAN INSULIN A-CHAIN (1-21) VARIANT (Y>E14), HUMAN INSULIN B-CHAIN (1-29) VARIANT (Y>H16, F>H25) CONJUGATED AT K29B AT ITS N6 TO (22S)-22,42-DICARBOXY10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23- TRIAZADOTETRACONTAN-1-OYL; N6.29B-((22S)-22,42-DICARBOXY-10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23-TRIAZADOTETRACONTAN-1-OYL)- (TYR14A>GLU, TYR16B>HIS, PHE25B>HIS)-DES-THR30B-HUMAN INSULIN

SYS